Tacrolimus-associated eosinophilic gastroenterocolitis in pediatric liver transplant recipients: Role of potential food allergies in pathogenesis

Pediatric Transplantation

Volumn 10, Issue 6, 2006, Pages 730-735

  Saeed, Shehzad A ^a,d   Integlia, Mark J ^a   Pleskow, Randi G ^a,b   Calenda, Kathleen A ^a   Rohrer, Richard J ^c   Dayal, Yogeshwar ^c   Grand, Richard J ^a,b  

^a TUFTS MEDICAL CENTER   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Eosinophilic gastroenterocolitis; Graft vs. host disease; Pediatric liver transplantation; Radioallergosorbent test

Indexed keywords

ACICLOVIR; AMINO ACID; AZATHIOPRINE; CROMOGLYCATE DISODIUM; CYCLOSPORIN A; GASTROCROME; IMMUNOGLOBULIN E; MACROLIDE; MILK PROTEIN; NEOCATE ONE PLUS; PEDIASURE; PEPTAMEN JR; PREDNISOLONE; PREGESTEMIL; STEROID; TACROLIMUS; UNCLASSIFIED DRUG; VIVONEX;

ABDOMINAL CRAMP; APLASTIC ANEMIA; ARTICLE; CASE REPORT; COLITIS; DIARRHEA; DIET RESTRICTION; DRUG SAFETY; ENTEROCOLITIS; EOSINOPHILIC GASTROENTERITIS; EPSTEIN BARR VIRUS; FOOD ALLERGY; GASTROENTEROCOLITIS; GASTROINTESTINAL SYMPTOM; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; HUMAN TISSUE; HYPERSENSITIVITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; LIVER GRAFT; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; PATHOGENESIS; PRESCHOOL CHILD; RADIOALLERGOSORBENT TEST; VIRUS INFECTION; WEANING;

CHILD; COLITIS; EOSINOPHILIA; FOOD HYPERSENSITIVITY; HUMANS; IMMUNOGLOBULIN E; IMMUNOSUPPRESSIVE AGENTS; INFANT; LIVER TRANSPLANTATION; MALE; TACROLIMUS;

EID: 33746903481     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2006.00538.x     Document Type: Article

References (21)

1. HOOKS MA. Tacrolimus, a new immunosuppressant-a review of the literature. Ann Pharmacother 1994: 28: 501-511.
2. MCDIARMID SV. The use of tacrolimus in pediatric liver transplantation. J Pediatr Gastroenterol Nutr 1998: 26: 90-102.
3. WALLEMACQ PE, REDING R. FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical and analytical aspects. Clin Chem 1993: 39: 2219-2228.
4. KAWAMURA N, FURUTA H, TAME A, et al. Extremely high serum level of IgE during immunosuppressive therapy: paradoxical effect of cyclosporine and tacrolimus. Int Arch Allergy Immunol 1997: 112: 422-424.
5. TREDE NS, WARWICK AB, ROSOFF PM, et al. Tacrolimus (FK506) in allogeneic bone marrow transplantation for severe anemia following orthotopic liver transplantation. Bone Marrow Transplant 1997: 20: 257-260.
6. LACAILLE F, LAURENT J, BOUSQUET J, et al. Life threatening food allergy in a child treated with FK506. J Pediatr Gastroenterol Nutr 1997: 25: 228-229.
7. INUI A, KOMATSU H, FUGISAWA T, et al. Food allergy and tacrolimus. J Pediatr Gastroenterol Nutr 1999: 28: 355-356.
8. NOWAK-WEGREZYN AH, SICHERER SH, CONOVER-WALKER MK, et al. Food allergy after pediatric organ transplantation with tacrolimus immunosuppression. J Allergy Clin Immunol 2001: 108: 146-147.
9. DHAWAN A, SEEMAYER TA, PINSISKI C, et al. Post transplant eosinophilic gastroentritis in children. Liver Transpl Surg 1997: 3: 591-593.
10. ROMERO R, ABRAMOWSKY CR, PILLEN T, et al. Peripheral eosinophilia and eosinophilic gastroenteritis after pediatric liver transplantation. Pediatr Transplant 2003: 7: 484-488.
11. LYKAVIERIS P, FRAUGER E, HABES D, et al. Angioedema in pediatric liver transplant recipients under tacrolimus immunosuppression. Transplantation 2003: 75: 152-165.
12. MADSEN K, YANCHAR NL, SIGALET DL, et al. FK506 increases permeability in rat intestine by inhibiting mitochondrial function. Gastroenterology 1995: 109: 107-114.
13. GABE SM, BJRARNASON I, TOLON-GHAMARI Z, et al. The effect of tacrolimus (FK506) on intestinal barrier function and cellular energy production in humans. Gastroenterology 1998: 115: 67-74.
14. YANCHAR NL, RIEGEL TL, MARTIN G, et al. Tacrolimus (FK506) - its effects on intestinal glucose transport. Transplantation 1996: 61: 630-634.
15. RENZ H. The central role of T-cells in allergic sensitization and IgE regulation. Exp Dermatol 1995: 4: 173-182.
16. WANG SC, ZEEVI A, JORDAN ML, et al. Fk506, rapamycin and cyclosporine: effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line. Transplant Proc 1991: 23: 2920-2922.
17. WILHELM D, KIRCHNER H. T cells and their role in allergies. Exp Clin Immunogenet 1993: 10: 208-218.
18. VERCELLI D, JABARA HF, LAUENER RP, et al. IL-4 inhibits the synthesis of IFN-γ and induces the synthesis of IgE in human mixed lymphocyte cultures. J Immunol 1990: 144: 570-573.
19. RENZ H, LACK G, SALOGA J, et al. Inhibition of IgE production and normalization of airways responsiveness by sensitized CD8 T cells in a mouse model of allergen-induced sensitization. J Immunol 1994: 152: 351-360.
20. DIAZ-SANCHEZ D, NOBLE A, STAYNOV DZ, et al. Elimination of IgE regulatory rat CD8+ T cells in vivo differentially modulates interleukin-4 and interferon-γ but not interleukin-2 production by splenic T cells. Immunology 1993: 78: 513-519.
21. HANIFIN JM, SCHNEIDER LC, LEUNG DYM, et al. Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol 1993: 28: 189-197.